Neurocognitive Function After Proton Therapy in Children and Adolescents

Last updated: February 4, 2025
Sponsor: Technische Universität Dresden
Overall Status: Active - Recruiting

Phase

N/A

Condition

Astrocytoma

Glioblastoma Multiforme

Treatment

N/A

Clinical Study ID

NCT04066465
STR-ELBE-Pro-Kids-2019
  • Ages 8-18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Brain tumors are the second most frequent malignant diseases in children and adolescents. In the study the short and medium term consequences of proton therapy on cognitive processes in particular on executive functions in pediatric patients shall be highlighted/analysed/evalutated. In a second step, these results are to be compared with

  1. a group of children and adolescents who had only /exclusively had operative therapy and

  2. with a healthy control group. Thus, the extent to which these treatment options differ in terms of their short and medium-term effect is assessed. Methods of neurocognitive/neurophysiology brain research approaches are applied that may potentially visualize even small / subtle changes in mental activities/neurocognitive function. Therefore the effects of treatment can be evaluated and the neuropsychological outcome of children and adolescents with brain tumors can be improved.

Eligibility Criteria

Inclusion

Indication: Patients with primary brain tumor

Inclusion Criteria:

  • all groups: Patients in childhood and adolescence between 8-18 years of age

  • all groups: no prior radiotherapy of the brain,

  • all groups: The patient is able to perform repeated neuropsychological tests (approx. 1 hour per examination),

  • all groups: corrected visual acuity not impaired below 80% or no subjectiveindication of visual acuity impairment,

  • all groups: corrected hearing not impaired or no subjective evidence of hearingimpairment,

  • all groups: Patient is able to perform follow-up examinations,

  • all groups: written consent of the patient/parent or guardian.

  • Brain tumour groups with/without irradiation: Primary brain tumour

  • brain tumor groups with/without radiation: curative or long-term palliativeintention of therapy

  • brain tumor groups with/without irradiation: life expectancy > 3 years

  • Irradiation group only: planned proton therapy with a local radiation dose of atleast 40 Gy(RBE)

Exclusion

Exclusion Criteria:

  • Patients under 8 or over 18 years of age (We limit the study to children over 8years of age due to the fact that executive functions mature very late.)

  • Brain metastases from extracerebral tumors

  • Patient receives intrathecal chemotherapy

  • pure palliative treatment concept

  • The patient is not able to perform repeated neuropsychological tests (approx. 1 hourper examination).

  • Chronic diseases that may affect the results of neurological EEG andneuropsychological examinations.

  • The patient is not in a position to perform follow-up examinations

  • no written consent of the patient / parent or legal guardian

  • Participation in an intervention study whose procedures contradict those of thepresent study

Study Design

Total Participants: 90
Study Start date:
September 01, 2019
Estimated Completion Date:
December 31, 2027

Study Description

Radio(chemo)therapy with protons is conducted according to current treatment standards or, for patients participating in a clinical intervention study, according to the study protocols of the GPOH. Only patients with prescribed radiation doses > 40 Gy (RBE) will be included. Treatment planning, the target volume and radiotherapy will be performed according to the current treatment standards. For patients participating in a clinical intervention study, radiotherapy is corresponding to study protocol of the GPOH. Risk organs (e.g. brain stem, chiasma, optic nerves, gll. Lacrimals, lenses, inner ears and spine) are contoured and the radiation doses for these organs are limited according to institutional guidelines. Radiotherapy is performed according to guidelines, i.e. 5 days a week for 4-6 weeks, usually on an outpatient basis.

Connect with a study center

  • University Hospital Carl GUstav Carus Dresden, Child and adolescent psychiatry and psychotherapy

    Dresden, Saxony 01307
    Germany

    Active - Recruiting

  • University Hospital Carl GUstav Carus Dresden, Department of Neuropaediatrics

    Dresden, Saxony 01307
    Germany

    Active - Recruiting

  • University Hospital Carl GUstav Carus Dresden, Department of Radiation Therapy and Radiation Oncology

    Dresden, Saxony 01307
    Germany

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.